MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview
  • Bile Acids: A Novel Multiple Sclerosis Therapy?
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

COVID-19

Facebook Live: COVID-19 & Multiple Sclerosis

MStranslate
March 23, 2020
Q&A, Videos
On March 20, 2020, we conducted a very important Facebook Live broadcast, discussing what is known about coronavirus (COVID-19) and its implications for people living with multiple sclerosis. The opportunity...
sleep conditions

Sleep Conditions and Their Impact on Multiple Sclerosis

MStranslate
March 11, 2020
Fatigue, Lifestyle, Quality of Life, Symptoms
1 Comment
We hate to state the obvious but... A while ago a study was published that showed that one of the main causes of fatigue in people living with multiple sclerosis was difficulty sleeping. Upon sharing these...
remyelination

Facebook Live: Remyelination – March 2020

MStranslate
March 11, 2020
Q&A, Remyelination, Videos
1 Comment
On March 5, 2020, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss one of the most important topics in multiple sclerosis research,...
friendship

The Importance of Friendship for People Living With MS

MStranslate
March 3, 2020
Community, Quality of Life, Symptoms
“Friendship is born at that moment when one person says to another: ‘What! You too? I thought I was the only one.” - C.S Lewis Two of the most common feelings that we hear from people living...
mesenchymal stem cell

Mesenchymal Stem Cell Trial for Multiple Sclerosis

MStranslate
February 2, 2020
Conferences, Dr Travis Stiles, ECTRIMS, Stem Cells, Treatments
EXCLUSIVE INTERVIEW At ECTRIMS Congress 2019, we had the privilege of interviewing Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about the exciting results from his mesenchymal stem cell trial...
AHSCT

BEAT-MS Trial to Compare AHSCT to MS Treatments

MStranslate
January 14, 2020
Research, Stem Cells, Treatments
Over recent years, we have seen a large expansion in the number of available treatments for people living with relapsing-remitting multiple sclerosis (RRMS).  As well as this, we have recently seen a number...
Facebook Live

Facebook Live: Research Update – December 2019

MStranslate
December 5, 2019
Community, Q&A, Research
On December 4, 2019, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss a number of recent important developments in multiple sclerosis...
siponimod

Research Reflections: Siponimod Trial Results

MStranslate
November 21, 2019
Clinical Trials, Research, Treatments
1 Comment
In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod). With this therapy recently approved for the treatment of...
multiple sclerosis research

Emerging Themes in Multiple Sclerosis Research

MStranslate
November 5, 2019
Opinion, Research, Videos
On a recent visit to Melbourne, Australia, Prof Amit Bar-Or (University of Pennsylvania) sat down with Prof Trevor Kilpatrick (University of Melbourne, Florey Institute of Neuroscience and Mental Health) to...
Employment

Employment & Multiple Sclerosis: Feature Week

MStranslate
October 16, 2019
Collaboration, Research
...
  1. 5
  2. 6
  3. 7
  4. 8
  5. 9
  6. 10
  7. 11

Posts

  • Multiple Sclerosis in 2025 – Key Developments to Date
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Diet & Clinical Outcomes in Multiple Sclerosis
  • Study Provides New Insights Into Disease Progression
  • ECTRIMS 2024: An Overview

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkValues & Standards